Cost-effectiveness of hepatitis B vaccination using HEPLISAV in selected adult populations compared to Engerix-B vaccine

Category Primary study
JournalVaccine
Year 2013
This is an economic evaluation that meets the criteria for inclusion on NHS EED.
Epistemonikos ID: 87555bcdee2b6760081837625b999e033b4cf875
First added on: Apr 19, 2023